Platelet Aggregation Inhibitor class drugs

7 results

  • aspirin and extended-release dipyridamole

    (Aspirin and Extended-Release Dipyridamole)
    AvKARE
    Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke caused by thrombosis.
    Medication Details
    Drug Interactions

  • asprin and extended-release dipyridamole

    (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
    Glenmark Pharmaceuticals Inc., USA
    Aspirin and extended-release dipyridamole capsules are indicated for reducing the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke due to thrombosis.
    Medication Details
    Drug Interactions

  • butalbital, aspirin, and caffeine

    (butalbital, aspirin, and caffeine)
    Chartwell RX, LLC
    Butalbital, aspirin, and caffeine capsules are indicated for relieving tension or muscle contraction headache symptoms. There is insufficient evidence for their efficacy in multiple recurrent headaches. Caution is advised due to the potential for habit formation and abuse associated with butalbital.
    Medication Details
    Drug Interactions

  • butalbital, aspirin, caffeine and codeine phosphate

    (BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE)
    Amneal Pharmaceuticals of New York, LLC
    BUTALBITAL, ASPIRIN, CAFFEINE, and CODEINE PHOSPHATE are indicated for managing tension headaches when non-opioid analgesics are ineffective. Due to addiction risks, it is recommended for patients who cannot tolerate or do not achieve adequate relief from non-opioid treatments and should not be used long-term.
    Medication Details
    Drug Interactions

  • eptifibatide

    (Eptifibatide)
    Hainan Shuangcheng Pharmaceuticals Co., Ltd.
    Eptifibatide injection is indicated to reduce the risk of death or new myocardial infarction in patients with acute coronary syndrome (ACS) and to decrease the rate of adverse outcomes in patients undergoing percutaneous coronary intervention (PCI), including those receiving intracoronary stenting.
    Medication Details
    Drug Interactions

  • norgesic forte

    (Orphenadrine Citrate, Aspirin and Caffeine)
    Poly Pharmaceuticals, Inc.
    Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated for symptomatic relief of mild to moderate pain from acute musculoskeletal disorders and as an adjunct to rest and physical therapy for discomfort associated with these conditions. The action of orphenadrine may relate to its analgesic properties.
    Medication Details
    Drug Interactions

  • oxycodone and aspirin

    (Oxycodone and Aspirin)
    Epic Pharma, LLC
    Oxycodone and aspirin tablets are indicated for managing severe pain that requires an opioid analgesic when alternative treatments are ineffective or intolerable. Due to addiction and misuse risks, they should be used only when other options fail.
    Medication Details
    Drug Interactions